Cheknev S B, Mikovskaia O I, Meshkova E N, Khaldin A A, Samgin M A, Malinovskaia V V
Vopr Virusol. 1994 May-Jun;39(3):125-8.
Natural killer cell activity (NK) in parallel with the interferon (IFN)-alpha and IFN-gamma production as well as with a level of IFN in the blood serum were studied in 15 patients with relapsing herpes genitalis (RHG). Rhidostin, well known as an IFN-alpha inducer, was used in a dose of 2 mg once daily for 3 days subcutaneously up to a total dose of 8 mg of the preparation. The NK cell activity and IFN-alpha production were shown to decrease in RHG more significantly in the stage of remission than during the relapse of the process. As a result of rhidostin therapy the NK cell activity was restored simultaneously with the positive clinical effect of the drug. Rhidostin was found to be an efficient modifier of the IFN system functioning in patients with RHG. The above data allow a conclusion that rhidostin exhibiting an independent antiviral and immunostimulating action might be useful in patients with a remission of RHG for prevention of its relapses.
对15例复发性生殖器疱疹(RHG)患者的自然杀伤细胞活性(NK)以及α干扰素(IFN-α)和γ干扰素(IFN-γ)的产生情况,连同血清中IFN水平进行了研究。瑞多斯汀是一种广为人知的IFN-α诱导剂,皮下注射剂量为每日1次,每次2 mg,共3天,制剂总剂量达8 mg。结果显示,与疾病复发阶段相比,在缓解期RHG患者的NK细胞活性和IFN-α产生下降更为显著。瑞多斯汀治疗后,NK细胞活性恢复,同时药物产生了积极的临床效果。研究发现瑞多斯汀是RHG患者IFN系统功能的有效调节剂。上述数据表明,具有独立抗病毒和免疫刺激作用的瑞多斯汀可能对处于RHG缓解期的患者预防疾病复发有用。